openPR Logo
Press release

Investigation announced for Investors who lost money with Embecta Corp. (NASDAQ: EMBC) Shares

01-13-2023 05:04 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Embecta Corp. (NASDAQ: EMBC) shares over potential securities laws violations by Embecta Corp.

An investigation for investors in Embecta Corp. (NASDAQ: EMBC) shares over potential securities laws violations by Embecta Corp.

An investigation was announced for investors of Embecta Corp. (NASDAQ: EMBC) shares over potential securities laws violations by Embecta Corp.

Investors who purchased shares of Embecta Corp. (NASDAQ: EMBC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Embecta Corp. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Parsippany, NJ based Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. On December 20, 2022, Embecta Corp. released Fiscal 2022 Fourth Quarter and Full Year Financial Results. Among the items reported, Embecta stated that "an impairment charge of $58.9 million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed, and a $5.5 million charge related to purchase commitments associated with the abandonment of the assets."

Shares of Embecta Corp. (NASDAQ: EMBC) declined from $36.64 per share on December 14, 2022, to as low as $24.11 per share on December 20, 2022.

Those who purchased shares of Embecta Corp. (NASDAQ: EMBC) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with Embecta Corp. (NASDAQ: EMBC) Shares here

News-ID: 2881704 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Embecta

Diabetes Care Market Outlook (2025-2032): Growth Drivers, Innovation Trends & Em …
Diabetes Care Market is estimated to be valued at USD 34.51 Bn in 2025 and is expected to reach USD 62.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032. The Diabetes Care Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Diabetes Care Market dynamics. The report includes Porter's Five Forces to
Diabetes Care Market to See Booming Growth 2025-2032 | Medtronic, Abbott, Pumps …
Coherent Market Insights Reports has released a detailed research analysis on the "Diabetes Care Market 2025", highlighting key trends, growth dynamics, and forecast insights through 2032. This comprehensive report presents an in-depth evaluation of the market landscape, analyzing the factors that influence industry growth, including manufacturers, suppliers, market participants, and end users. It offers valuable insights into the core drivers fueling market expansion across various segments such as product type,
Diabetes Care Market Set for Significant Growth | 2025-2032 Report | Medtronic, …
The diabetes care market is estimated to be valued at USD 34.51 billion in 2025 and is expected to reach USD 62.73 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032. Latest Qualitative Research Report on the Diabetes Care Market Size 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to
Diabetes Care Market Size, Applications, and Global Forecast 2025-2032| Medtroni …
The diabetes care market is estimated to be valued at USD 34.51 billion in 2025 and is expected to reach USD 62.73 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032. Latest Qualitative Research Report on the Diabetes Care Market Size 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to
Diabetes Care Market Is Booming So Rapidly 2025-2032 | Medtronic, Abbott, Pumps …
The Latest comprehensive Research Report on the Diabetes Care Market 2025-2032, Outlook is performed by determining industry drivers, dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. The Diabetes Care Market report has been designed after a Research Scope and Methodologies of various segments such as share, demand analysis, growth figure,
Diabetes Care Market In-depth Insights, Top companies Analysis Forecast by 2032 …
The diabetes care market is estimated to be valued at USD 34.51 billion in 2025 and is expected to reach USD 62.73 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032. The Latest comprehensive Research Report on the Diabetes Care Market 2025-2032, Outlook is performed by determining industry drivers, dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments.